Compare · ESAB vs TMO
ESAB vs TMO
Side-by-side comparison of ESAB Corporation (ESAB) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ESAB and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $211.18B, about 41.1x ESAB ($5.14B).
- Over the past year, ESAB is down 35.9% and TMO is up 17.2% - TMO leads by 53.0 points.
- ESAB has been more active in the news (4 items in the past 4 weeks vs 3 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 21 for ESAB).
- Company
- ESAB Corporation
- Thermo Fisher Scientific Inc
- Price
- $84.49+1.04%
- $568.15-0.75%
- Market cap
- $5.14B
- $211.18B
- 1M return
- -12.84%
- +15.46%
- 1Y return
- -35.88%
- +17.16%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- News (4w)
- 4
- 3
- Recent ratings
- 21
- 25
ESAB Corporation
ESAB Corporation formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. Its comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, including electrodes, nozzles, shields, and tips. The company's fabrication technology equipment ranges from portable welding machines to large customized automated cutting and welding systems. It also offers a range of digital software and solutions to help its customers increase their productivity, remotely monitor their welding operations, and digitize their documentation. The company sells its products under the ESAB brand to various end markets, including general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences. It offers its products through independent distributors and direct salespeople. ESAB Corporation was incorporated in 2021 and is based in Wilmington, Delaware.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ESAB
- SEC Form 4 filed by EVP, Business Operations Bhagwakar Ranjana N
- ESAB Corporation Schedules Second Quarter 2026 Earnings Release and Conference Call
- SEC Form 4 filed by EVP, Business Operations Bhagwakar Ranjana N
- SEC Form 3 filed by new insider Bhagwakar Ranjana N
- Executive Chair of Board Rales Mitchell P was granted 596 shares, increasing direct ownership by 4% to 16,432 units (SEC Form 4)
- SEC Form 4 filed by Director Teirlinck Didier P
- SEC Form 4 filed by Director Lutz Robert S
- SEC Form 424B7 filed by ESAB Corporation
- DA Davidson initiated coverage on ESAB Corp. with a new price target
- SEC Form 4 filed by Executive Chair of Board Rales Mitchell P
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports Second Quarter 2026 Results
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target